Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment.

Abstract:

:Vascular endothelial growth factor-A is widely used in clinical trials for the treatment of cardiac ischemia. VEGF-A was recently suggested to act in a proinflammatory manner, which could aggravate adjacent atherogenesis in VEGF-A-based therapy. To assess potential bystander effects, VEGF-A was focally overexpressed in advanced atherosclerotic plaques in ApoE-/- mice. Sheer-induced carotid artery plaques were transluminally incubated with Ad.hVEGF-A leading to neointimal overexpression of VEGF-A. Ad.hVEGF-A treatment of pre-existing lesions was seen to promote plaque expansion, with a concomitant increase in macrophage and lipid content, whereas it lowered collagen content. In general, Ad.hVEGF-A-treated plaques displayed a more vulnerable phenotype. VEGF-A overexpression was not accompanied by increased microvessel development in the neointima, suggesting that VEGF-A destabilizes atherosclerotic plaques through an angiogenesis-independent mechanism. Intravital microscopy confirmed that treatment with Ad.hVEGF-A led to an increased monocyte adhesion, which was mediated by a VCAM-1/PECAM-1-dependent pathway. VEGF-A indeed induced a differential expression of VCAM-1 and PECAM-1 in endothelial cells. Our data underline the importance of regular monitoring of stenotic vessels adjacent to the site of VEGF-A application. We propose that VCAM-1/PECAM-1-directed cotherapy may be an efficient strategy to prevent bystander effects of focal VEGF-A therapy in patients suffering from cardiovascular disease.

journal_name

Blood

journal_title

Blood

authors

Lucerna M,Zernecke A,de Nooijer R,de Jager SC,Bot I,van der Lans C,Kholova I,Liehn EA,van Berkel TJ,Yla-Herttuala S,Weber C,Biessen EA

doi

10.1182/blood-2006-07-031773

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

122-9

issue

1

eissn

0006-4971

issn

1528-0020

pii

blood-2006-07-031773

journal_volume

109

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha.

    abstract::Protein kinase C (PKC) activity has a recognized role in mediating apoptosis. However, the role of individual PKC isoforms in apoptosis is poorly defined. Therefore, we investigated the translocation of individual PKC isoforms during radiation-induced apoptosis with and without rescue from apoptosis by granulocyte-mac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kelly ML,Tang Y,Rosensweig N,Clejan S,Beckman BS

    更新日期:1998-07-15 00:00:00

  • Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis.

    abstract::Therapy for childhood acute lymphoblastic leukemia (ALL) is associated with 5-year survival rates of ∼90% even after largely eliminating cranial radiation. This meta-analysis assesses the long-term neurocognitive functioning after chemotherapy-only regimens among survivors of childhood ALL. We conducted a systematic r...

    journal_title:Blood

    pub_type: 杂志文章,meta分析,评审

    doi:10.1182/blood-2015-02-627414

    authors: Iyer NS,Balsamo LM,Bracken MB,Kadan-Lottick NS

    更新日期:2015-07-16 00:00:00

  • A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice.

    abstract::During thrombopoiesis, maturing megakaryocytes (MKs) migrate within the complex bone marrow stromal microenvironment from the proliferative osteoblastic niche to the capillary-rich vascular niche where proplatelet formation and platelet release occurs. This physiologic process involves proliferation, differentiation, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-050740

    authors: Dhanjal TS,Pendaries C,Ross EA,Larson MK,Protty MB,Buckley CD,Watson SP

    更新日期:2007-05-15 00:00:00

  • Near-normal circulatory survival of rabbit red cells exposed to high levels of Ca and ionophore in vitro.

    abstract::The belief is widely held, on the basis of indirect evidence, that a substantial, even brief elevation of red cell Ca content must result in a marked shortening of circulatory survival. To test this notion directly, we exposed rabbit red cells in vitro to the ionophore A23187 and Ca so as to produce sustained uniform ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bookchin RM,Roth EF Jr,Lew VL

    更新日期:1985-07-01 00:00:00

  • Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment.

    abstract::Expression of the arterial marker molecule ephrinB2 in endothelial cells is a prerequisite for adequate remodeling processes of the developing or angiogenic vasculature. Although its role in these processes has been extensively studied, the impact of ephrinB2 on the remodeling of adult arteries is largely unknown. To ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-12-128835

    authors: Korff T,Braun J,Pfaff D,Augustin HG,Hecker M

    更新日期:2008-07-01 00:00:00

  • JAK2 inhibitors for myeloproliferative neoplasms: what is next?

    abstract::Since its approval in 2011, the Janus kinase 1/2 (JAK1/2) inhibitor ruxolitinib has evolved to become the centerpiece of therapy for myelofibrosis (MF), and its use in patients with hydroxyurea resistant or intolerant polycythemia vera (PV) is steadily increasing. Several other JAK2 inhibitors have entered clinical te...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-04-742288

    authors: Bose P,Verstovsek S

    更新日期:2017-07-13 00:00:00

  • HIV-1 Nef drives macrophages into hiding.

    abstract::In this issue of Blood, Vérollet et al show that expression of the HIV-1–derived protein Nef alters the migratory mode adopted by macrophages, enhancing macrophage tissue infiltration and explaining the observed accumulation of tissue-resident macrophages in some HIV-infected patients. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-01-618983

    authors: Morley SC

    更新日期:2015-03-05 00:00:00

  • Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytes.

    abstract::Multiple observations support the existence of developmental differences in megakaryocytopoiesis. We have previously shown that neonatal megakaryocyte (MK) progenitors are hyperproliferative and give rise to MKs smaller and of lower ploidy than adult MKs. Based on these characteristics, neonatal MKs have been consider...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-293092

    authors: Liu ZJ,Italiano J Jr,Ferrer-Marin F,Gutti R,Bailey M,Poterjoy B,Rimsza L,Sola-Visner M

    更新日期:2011-04-14 00:00:00

  • Selective activation of TACI by syndecan-2.

    abstract::B-lymphocyte homeostasis and function are regulated by complementary actions of the TNFR family members TACI, BCMA, and BAFF-R, which are expressed by mature B cells. How these receptors are differentially activated is not entirely understood, because the primary ligand BAFF binds to all three. We searched for alterna...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-01-0256

    authors: Bischof D,Elsawa SF,Mantchev G,Yoon J,Michels GE,Nilson A,Sutor SL,Platt JL,Ansell SM,von Bulow G,Bram RJ

    更新日期:2006-04-15 00:00:00

  • Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

    abstract::Approximately 40% of children with acute myeloid leukemia (AML) who respond to initial therapy subsequently relapse. Multidimensional flow cytometry employing a standardized panel of monoclonal antibodies enables the detection of small numbers of occult leukemic cells that persist during therapy using technology adapt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-10-3064

    authors: Sievers EL,Lange BJ,Alonzo TA,Gerbing RB,Bernstein ID,Smith FO,Arceci RJ,Woods WG,Loken MR

    更新日期:2003-05-01 00:00:00

  • In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation.

    abstract::To investigate whether the migratory ability of peripheral blood-derived CD34+ cells of patients undergoing autologous peripheral blood stem cell transplantation is related to the homing efficiency of these cells, the migration in vitro of these cells was determined and correlated with in vivo hematopoietic recovery. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.3.799

    authors: Voermans C,Kooi ML,Rodenhuis S,van der Lelie H,van der Schoot CE,Gerritsen WR

    更新日期:2001-02-01 00:00:00

  • Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction)

    abstract::Neutrophilic-chronic myeloid leukemia (CML-N) is a rare myeloproliferative disorder that runs a much more benign course than chronic myeloid leukemia, and for which no specific underlying molecular lesion has been described so far. We have analyzed the genomic DNA by Southern blotting and the BCR/ABL hybrid gene trans...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pane F,Frigeri F,Sindona M,Luciano L,Ferrara F,Cimino R,Meloni G,Saglio G,Salvatore F,Rotoli B

    更新日期:1996-10-01 00:00:00

  • Tissue type plasminogen activator regulates myeloid-cell dependent neoangiogenesis during tissue regeneration.

    abstract::Ischemia of the heart, brain, and limbs is a leading cause of morbidity and mortality worldwide. Treatment with tissue type plasminogen activator (tPA) can dissolve blood clots and can ameliorate the clinical outcome in ischemic diseases. But the underlying mechanism by which tPA improves ischemic tissue regeneration ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-08-236851

    authors: Ohki M,Ohki Y,Ishihara M,Nishida C,Tashiro Y,Akiyama H,Komiyama H,Lund LR,Nitta A,Yamada K,Zhu Z,Ogawa H,Yagita H,Okumura K,Nakauchi H,Werb Z,Heissig B,Hattori K

    更新日期:2010-05-27 00:00:00

  • Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups.

    abstract::Genes of the major histocompatibility complex (MHC) are associated with susceptibility to different immune and nonimmune mediated diseases. We had reported that the drug adverse reaction, clozapine-induced agranulocytosis (CA), is associated with different HLA types and HSP70 variants in Ashkenazi Jewish and non-Jewis...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Turbay D,Lieberman J,Alper CA,Delgado JC,Corzo D,Yunis JJ,Yunis EJ

    更新日期:1997-06-01 00:00:00

  • Fetal erythropoiesis in juvenile chronic myelocytic leukemia.

    abstract::Red cell enzymes, 2,3-diphosphoglycerate (2,3-DPG) and adenosine triphosphate (ATP), were evaluated in a 23-mo-old boy with juvenile chronic myelocytic leukemia (JCML) at the onset of his illness and 6 mo later during the accelerated phase. The activities of the age-dependent red cell enzymes, hexokinase, aldolase, py...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Travis SF

    更新日期:1983-09-01 00:00:00

  • Identification of a restriction fragment length polymorphism involving the oncogene ETS-1 on chromosome 11q23.

    abstract::Twenty four samples of DNA from 23 unrelated individuals were analyzed for the presence of a novel restriction fragment length polymorphism (RFLP) involving the proto-oncogene ETS-1 at an Xba I site. Four samples from unrelated individuals lacked an Xba I site, giving rise to a longer restriction fragment detectable b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Savage PD,Hanson CA,Kersey JH

    更新日期:1987-07-01 00:00:00

  • Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party.

    abstract::The median age of chronic myeloid leukemia (CML) patients is ~60 years, and age is still considered an important prognostic factor, included in Sokal and EURO risk scores. However, few data are available about the long-term outcome of older patients treated with imatinib (IM) frontline. We analyzed the relationship be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-324228

    authors: Gugliotta G,Castagnetti F,Palandri F,Breccia M,Intermesoli T,Capucci A,Martino B,Pregno P,Rupoli S,Ferrero D,Gherlinzoni F,Montefusco E,Bocchia M,Tiribelli M,Pierri I,Grifoni F,Marzocchi G,Amabile M,Testoni N,Martin

    更新日期:2011-05-26 00:00:00

  • GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.

    abstract::Children with constitutional trisomy 21 (Down syndrome) have an approximately 500-fold increased risk of developing acute megakaryoblastic leukemia (AMKL), a form of acute myeloid leukemia. Unique to newborn infants with Down syndrome is a transient leukemia (TL), also referred to as transient myeloproliferative syndr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0013

    authors: Hitzler JK,Cheung J,Li Y,Scherer SW,Zipursky A

    更新日期:2003-06-01 00:00:00

  • Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.

    abstract::The stages of human natural killer (NK) cell differentiation are not well established. Culturing CD34(+) progenitors with interleukin 7 (IL-7), IL-15, stem cell factor (SCF), FLT-3L, and murine fetal liver cell line (EL08.1D2), we identified 2 nonoverlapping subsets of differentiating CD56(+) cells based on CD117 and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-04-020198

    authors: Grzywacz B,Kataria N,Sikora M,Oostendorp RA,Dzierzak EA,Blazar BR,Miller JS,Verneris MR

    更新日期:2006-12-01 00:00:00

  • A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.

    abstract::This phase 2 study evaluated the efficacy and safety of the oral farnesyltransferase inhibitor tipifarnib in adults with refractory or relapsed acute myeloid leukemia (AML). Patients (n=252) received tipifarnib 600 mg twice a day for 21 days in 28-day cycles. Median age was 62 years; 99 (39%) patients were 65 years or...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-046144

    authors: Harousseau JL,Lancet JE,Reiffers J,Lowenberg B,Thomas X,Huguet F,Fenaux P,Zhang S,Rackoff W,De Porre P,Stone R,Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group.

    更新日期:2007-06-15 00:00:00

  • Anti-CD33 monoclonal antibody and etoposide/cytosine arabinoside combinations for the ex vivo purification of bone marrow in acute nonlymphocytic leukemia.

    abstract::Pharmacologic and immunologic methods of ex-vivo bone marrow (BM) purging for acute nonlymphocytic leukemia (ANLL) were combined to augment the effect of either method alone. Etoposide (VP16; 20 to 30 micrograms/mL) with or without cytosine arabinoside (Ara C; 10 mg/mL) was used in tandem with the anti-CD33 monoclonal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stiff PJ,Schulz WC,Bishop M,Marks L

    更新日期:1991-01-15 00:00:00

  • Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage.

    abstract::Intracranial hemorrhage is the third most frequent cause of cerebrovascular disease, but few genetic risk factors have been associated with its development. Recently, it has been reported that some polymorphisms that affect clotting factors increase the risk for thrombosis. However, reports have analyzed the effect of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.10.2979

    authors: Corral J,Iniesta JA,González-Conejero R,Villalón M,Vicente V

    更新日期:2001-05-15 00:00:00

  • Immunogenic nature of a Pol gene product of HTLV-III/LAV.

    abstract::The present studies were initiated to define the coding region of a 34 kilodalton (kd) protein (p34) frequently observed with antibodies from HTLV-III/LAV-infected people by immunoblotting and radioimmunoprecipitation (RIP) techniques. We have directly mapped this viral protein to the pol gene of HTLV-III/LAV by radio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Allan JS,Coligan JE,Lee TH,Barin F,Kanki PJ,M'Boup S,McLane MF,Groopman JE,Essex M

    更新日期:1987-01-01 00:00:00

  • Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.

    abstract::We tested baseline positron emission tomography (PET)/computed tomography (CT) as a measure of total tumor burden to better identify high-risk patients with early-stage Hodgkin lymphoma (HL). Patients with stage I-II HL enrolled in the standard arm (combined modality treatment) of the H10 trial (NCT00433433) with avai...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2017-07-795476

    authors: Cottereau AS,Versari A,Loft A,Casasnovas O,Bellei M,Ricci R,Bardet S,Castagnoli A,Brice P,Raemaekers J,Deau B,Fortpied C,Raveloarivahy T,Van Zele E,Chartier L,Vander Borght T,Federico M,Hutchings M,Ricardi U,Andre M

    更新日期:2018-03-29 00:00:00

  • Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia.

    abstract::The healthy mother of a child with transient immune neutropenia was found to be "NA-null." The mother's neutrophils did not react with anti-NA1 and anti-NA2 antibodies (polyclonal human alloantibodies and mouse monoclonal antibodies). A healthy donor was discovered during routine neutrophil antigen typing whose neutro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Huizinga TW,Kuijpers RW,Kleijer M,Schulpen TW,Cuypers HT,Roos D,von dem Borne AE

    更新日期:1990-11-15 00:00:00

  • HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism.

    abstract::The finding that the risk of relapse in hematologic malignancy decreases after allogeneic hematopoietic stem cell transplantation (HSCT) has lead to the concept of a graft-versus-leukemia (GVL) effect. However, this beneficial effect is considered to be frequently offset by graft-versus-host disease (GVHD). Thus, impr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-08-171934

    authors: Kawase T,Matsuo K,Kashiwase K,Inoko H,Saji H,Ogawa S,Kato S,Sasazuki T,Kodera Y,Morishima Y,Japan Marrow Donor Program.

    更新日期:2009-03-19 00:00:00

  • Macrophage metabolic adaptation to heme detoxification involves CO-dependent activation of the pentose phosphate pathway.

    abstract::Heme is an essential cofactor for numerous cellular functions, but release of free heme during hemolysis results in oxidative tissue damage, vascular dysfunction, and inflammation. Macrophages play a key protective role in heme clearance; however, the mechanisms that regulate metabolic adaptations that are required fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020004964

    authors: Bories GFP,Yeudall S,Serbulea V,Fox TE,Isakson BE,Leitinger N

    更新日期:2020-09-24 00:00:00

  • Risk organ + LCH gets the one-two punch?

    abstract::In this issue of Blood, Donadieu et al present what may be the most encouraging data to date on a group of patients with Langerhans cell histiocytosis (LCH), which historically has poor disease-free survival and poor overall survival. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2015-08-661496

    authors: Stine KC

    更新日期:2015-09-17 00:00:00

  • Transcriptional and posttranscriptional modulation of human neutrophil elastase gene expression.

    abstract::Human neutrophil elastase (NE), a 29-Kd potent serine protease stored in azurophilic granules of mature neutrophils, is coded for by the NE gene, a single copy gene with 5 exons spanning a 6-kb segment of chromosome 11 at q14. With the knowledge that the NE gene expression is limited to early myeloid cell differentiat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yoshimura K,Crystal RG

    更新日期:1992-05-15 00:00:00

  • Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures.

    abstract::The onset of hematopoiesis in the mouse embryo and in the embryonic stem (ES) cell differentiation model is defined by the emergence of the hemangioblast, a progenitor with both hematopoietic and vascular potential. While there is evidence for the existence of a hemangioblast in the mouse, it is unclear if this progen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-047704

    authors: Kennedy M,D'Souza SL,Lynch-Kattman M,Schwantz S,Keller G

    更新日期:2007-04-01 00:00:00